Foto del docente

Elena Zamagni

Professoressa associata

Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale

Settore scientifico disciplinare: MED/15 MALATTIE DEL SANGUE

Pubblicazioni

Brioli, A; Perrone, G; Patriarca, F; Pezzi, A; Nobile, F; Ballerini, F; Motta, M R; Ronconi, S; Tacchetti, P; Catalano, L; Zannetti, B A; Rizzi, S; Volpe, S; Zamagni, E; Liberati, A M; Mancuso, K; Boccadoro, M; Davies, F E; Morgan, G J; Palumbo, A; Cavo, M, Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation, «BONE MARROW TRANSPLANTATION», 2015, 50, pp. 673 - 678 [articolo]

Patriarca, Francesca; Carobolante, Francesca; Zamagni, Elena; Montefusco, Vittorio; Bruno, Benedetto; Englaro, Emanuaela; Nanni, Cristina; Geatti, Onelio; Isola, Miriam; Sperotto, Alessandra; Buttignol, Silvia; Stocchi, Raffaella; Corradini, Paolo; Cavo, Michele; Fanin, Renato, The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation, «BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION», 2015, 21, pp. 1068 - 1073 [articolo]

Palumbo, A; Cavallo, F; Gay, F; Di Raimondo, F; Ben Yehuda, D; Petrucci, Mt; Pezzatti, S; Caravita, T; Cerrato, C; Ribakovsky, E; Genuardi, M; Cafro, A; Marcatti, M; Catalano, L; Offidani, M; Carella, Am; Zamagni, E; Patriarca, F; Musto, P; Evangelista, A; Ciccone, G; Omedé, P; Crippa, C; Corradini, P; Nagler, A; Boccadoro, M; Cavo, M., Autologous transplantation and maintenance therapy in multiple myeloma., «NEW ENGLAND JOURNAL OF MEDICINE», 2014, 371, pp. 895 - 905 [articolo]

Lucia Pantani;Elena Zamagni;Beatrice Anna Zannetti;Annalisa Pezzi;Paola Tacchetti;Annamaria Brioli;Katia Mancuso;Giulia Perrone;Serena Rocchi;Patrizia Tosi;Michele Cavo, Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes, «ANNALS OF HEMATOLOGY», 2014, 93, pp. 123 - 128 [articolo]

Tacchetti, P.; Terragna, C.; Galli, M.; Zamagni, E.; Petrucci, M. T.; Pezzi, A.; Montefusco, V.; Martello, M.; Tosi, P.; Baldini, L.; Peccatori, J.; Ruggieri, M.; Pantani, L.; Lazzaro, A.; Elice, F.; Rocchi, S.; Gozzetti, A.; Cavaletti, G.; Palumbo, A.; Cavo, M., Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study., «AMERICAN JOURNAL OF HEMATOLOGY», 2014, 89, pp. 1085 - 1091 [articolo]

Moreau, P; Cavo, M; Sonneveld, P; Rosinol, L; Attal, M; Pezzi, A; Goldschmidt, H; Lahuerta, Jj; Marit, G; Palumbo, A; van der Holt, B; Bladé, J; Petrucci, Mt; Neben, K; san Miguel, J; Patriarca, F; Lokhorst, H; Zamagni, E; Hulin, C; Gutierrez, N; Facon, T; Caillot, D; Benboubker, L; Harousseau, Jl; Leleu, X; Avet-Loiseau, H; Mary, Jy, Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-related death., «JOURNAL OF CLINICAL ONCOLOGY», 2014, 32, pp. 2173 - 2180 [articolo]

Enrica Borsi;Giulia Perrone;Carolina Terragna;Marina Martello;Elena Zamagni;Paola Tacchetti;Lucia Pantani;Annamaria Brioli;Angela Flores Dico;Beatrice Anna Zannetti;Serena Rocchi;Michele Cavo, HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment, «EXPERIMENTAL CELL RESEARCH», 2014, 328, pp. 444 - 455 [articolo]

Borsi E;Perrone G;Terragna C;Martello M;Dico AF;Solaini G;Baracca A;Sgarbi G;Pasquinelli G;Valente S;Zamagni E;Tacchetti P;Martinelli G;Cavo M, Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma., «ONCOTARGET», 2014, 5, pp. 1779 - 1792 [articolo]

Chng, Wj; Dispenzieri, A; Chim, Cs; Fonseca, R; Goldschmidt, H; Lentzsch, S; Munshi, N; Palumbo, A; Miguel, Js; Sonneveld, P; Cavo, M; Usmani, S; Durie, Bg; Avet-Loiseau, H; International Myeloma Working Group [..; Zamagni, E; ..], IMWG consensus on risk stratification in multiple myeloma., «LEUKEMIA», 2014, 28, pp. 269 - 277 [articolo]

Ludwig, H; Miguel, Js; Dimopoulos, Ma; Palumbo, A; Garcia Sanz, R; Powles, R; Lentzsch, S; Ming Chen, W; Hou, J; Jurczyszyn, A; Romeril, K; Hajek, R; Terpos, E; Shimizu, K; Joshua, D; Hungria, V; Rodriguez Morales, A; Ben-Yehuda, D; Sondergeld, P; Zamagni, E; Durie, B, International Myeloma Working Group recommendations for global myeloma care., «LEUKEMIA», 2014, 28, pp. 981 - 992 [articolo]

Rajkumar, S. Vincent; Dimopoulos, Meletios A.; Palumbo, Antonio; Blade, Joan; Merlini, Giampaolo; Mateos, María-Victoria; Kumar, Shaji; Hillengass, Jens; Kastritis, Efstathios; Richardson, Paul; Landgren, Ola; Paiva, Bruno; Dispenzieri, Angela; Weiss, Brendan; Leleu, Xavier; Zweegman, Sonja; Lonial, Sagar; Rosinol, Laura; Zamagni, Elena; Jagannath, Sundar; Sezer, Orhan; Kristinsson, Sigurdur Y.; Caers, Jo; Usmani, Saad Z.; Lahuerta, Juan José; Johnsen, Hans Erik; Beksac, Meral; Cavo, Michele; Goldschmidt, Hartmut; Terpos, Evangelos; Kyle, Robert A.; Anderson, Kenneth C.; Durie, Brian G.M.; Miguel, Jesus F.San, International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma, «THE LANCET ONCOLOGY», 2014, 15, pp. e538 - e548 [articolo]

Brioli, A; Tacchetti, P; Zamagni, E; Cavo, M, Maintenance therapy in newly diagnosed multiple myeloma: current recommendations., «EXPERT REVIEW OF ANTICANCER THERAPY», 2014, 14, pp. 581 - 594 [articolo]

Brioli, A; Zannetti, Ba; Zamagni, E; Tacchetti, P; Pantani, L; Mancuso, K; Pezzi, A; Rocchi, Serena; Cavo, M, Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma., «HAEMATOLOGICA», 2014, 99, pp. 242 - 243 [articolo]Open Access

Zamagni, E; Nanni, C; Tacchetti, P; Pantani, L; Marzocchi, G; Zannetti, B; Terragna, C; Mancuso, K; Rocchi, S; Pezzi, A; Testoni, N; Fanti, S; Cavo, M., Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2014, 14, pp. 101 - 104 [articolo]

Caers, J; Withofs, N; Hillengass, J; Simoni, P; Zamagni, E; Hustinx, R; Beguin, Y., The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma., «HAEMATOLOGICA», 2014, 99, pp. 629 - 637 [articolo]